Jan. 15, 2025 — Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. ... New Innovative Local Treatment ...

DelveInsight's Exosome Therapies Market Insights report includes a comprehensive understanding of emerging exosome therapies, market share ...

Italian authorities released the director of a notorious detention camp who had been arrested in Turin on an ICC war crimes warrant. Italian police were acting on an arrest warrant from the ...

Kerenida is currently approved to slow the progression of chronic kidney disease associated with type 2 diabetes. Bayer has submitted a supplemental new drug application (sNDA) for Kerendia ...

Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you. Daily news – Get the most important news from ...

Attacks between guerrilla groups have also seen thousands displaced from the country's Catatumbo region. The increased reward was announced on the day Maduro was sworn in for a third six-year term ...

Capricor Therapeutics has completed its submission of a biologics license application (BLA) seeking U.S. approval of deramiocel, the company’s cell therapy for heart muscle disease in people with ...

“We believe that the strength of this application is that deramiocel has shown in multiple clinical trials attenuation of the cardiac implications of DMD. We look forward to working with the FDA ...

The firm's analyst highlighted the completion of a rolling Biologics License Application (BLA) filing with the U.S. Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy ...